ASPI vs AVY vs LIN Stock Comparison

ASP Isotopes, Avery Dennison and Linde Prices as of Nov 13, 2026 Peers: Industry group
ASPI ASP Isotopes Inc.
$1.74 -15.9% 1M -78.3% 1Y
Market cap
$195.12M
P/E
–
Revenue (TTM)
$30.85M
Div. yield
–
Specialty Chemicals Basic Materials
1 win
AVY Avery Dennison Corp
$188.11 +9.4% 1M +6.6% 1Y
Market cap
$14.32B
P/E
20.2x
Revenue (TTM)
$9.36B
Div. yield
0.02%
Specialty Chemicals Basic Materials
5 wins
LIN Linde Plc
$526.06 +6.8% 1M +22.7% 1Y
Market cap
$243.32B
P/E
34.7x
Revenue (TTM)
$36.24B
Div. yield
0.01%
Industrial Gases Basic Materials
6 wins

Head to Head

12 decided of 12

Linde leads on 6 of the 12 questions below (Linde 6, Avery Dennison 5, ASP Isotopes 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionASPIAVYLINLeader
Larger companyMarket capitalisation $195.12M $14.32B $243.32B LIN
Cheaper on earningsLower P/E, profitable companies only -1.7x 20.2x 34.7x AVY
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 17.7x 31.3x AVY
Faster revenue growthRevenue growth, trailing twelve months +573.4% +6.8% +8.2% ASPI
More profitableNet margin, trailing twelve months -380.3% 7.6% 19.3% LIN
Better return on capitalReturn on invested capital -28.6% 14.4% 10.3% AVY
Less leveragedLower net debt / EBITDA 2.1x 2.2x 1.8x LIN
Higher dividend yieldTrailing dividend yield 0.00% 0.02% 0.01% AVY
Better 1-year returnPrice return, last 12 months -78.3% +6.6% +22.7% LIN
Better 5-year returnAnnualised price return, 5 years — -3.5%/yr +9.3%/yr LIN
Less volatileAnnualised volatility, 1 year 99.0% 24.0% 19.1% LIN
Higher overall scoreMean of the five percentile scores vs peers 24/100 68/100 56/100 AVY

Percentile Scorecard

ASPIAVYLIN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisASPIAVYLIN
Valuation 11 #86 of 96 63 #36 of 96 20 #77 of 96
Growth 11 #82 of 92 76 #23 of 92 55 #42 of 92
Profitability 9 #81 of 89 91 #9 of 89 96 #5 of 89
Financial Health 66 #33 of 96 36 #62 of 96 51 #48 of 96
Shareholder Returns – 73 #22 of 79 60 #32 of 79
Overall 24 68 56
  • ASPI ranked among 99 companies in Chemicals
  • AVY ranked among 99 companies in Chemicals
  • LIN ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodASPIAVYLINSPY
1 month -15.9%+9.4%+6.8% -2.0%
3 months -59.3%+5.1%+9.0% -2.8%
6 months -70.0%+20.4%+3.9% +2.0%
Year to date -67.5%+3.4%+23.4% +10.6%
1 year -78.3%+6.6%+22.7% +12.2%
3 years +14.5%+0.1%+30.3% +68.1%
3 years, per year +4.6%+0.0%+9.2% +18.9%
5 years —-16.5%+56.1% +61.4%
5 years, per year —-3.5%+9.3% +10.1%
10 years —+170.5%+346.4% +248.5%
10 years, per year —+10.5%+16.1% +13.3%

Risk

MeasureASPIAVYLINSPY
Volatility, 1Y 99.0%24.0%19.1% 13.6%
Downside volatility, 1Y 98.1%21.8%19.1% 13.9%
Beta vs S&P 500, 1Y 3.630.490.08 1.00
Return / volatility, 1Y -0.790.281.19 0.90
Max drawdown, 5Y -88.6%-33.3%-23.7% -25.4%
From 52-week high -79.5%-4.7%-3.8% -3.2%
52-week high $8.48$197.45$546.64 $779.14
52-week low $1.72$153.01$389.38 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleASPIAVYLIN
P/E now vs peer median -1.8xmedian 23.4x 20.1xmedian 23.4x 34.6xmedian 23.4x
P/S now vs peer median 7.3xmedian 1.3x 1.5xmedian 1.3x 6.7xmedian 1.3x
EV/EBITDA now vs peer median -0.3xmedian 12.7x 11.5xmedian 12.7x 20.3xmedian 12.7x
P/FCF now vs peer median -2.7xmedian 17.0x 13.7xmedian 17.0x 47.5xmedian 17.0x
P/B now vs peer median 0.8xmedian 1.5x 6.0xmedian 1.5x 5.9xmedian 1.5x
PEG now vs peer median 0.05median 1.72 1.25median 1.72 4.59median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsASPIAVYLIN
Revenue $30.85M $9.36B $36.24B
Gross profit $5.65M $2.70B $17.35B
Operating income -$99.07M $1.19B $9.16B
Net income -$117.34M $708.30M $7.03B
Free cash flow -$83.58M $1.04B $5.08B
R&D $22.04M – $147.00M
EPS (diluted) $-0.96 $9.33 $15.15
Cash & equivalents $219.60M $271.40M $3.95B
Total debt $59.77M $3.62B $26.70B
Shares (diluted) 122.72M 75.90M 462.51M
Enterprise value -$791.59M $13.36B $225.46B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricASPIAVYLIN
P/E -1.8x 20.1x 34.6x
P/FCF -2.7x 13.7x 47.5x
P/Operating cash flow -3.3x 11.7x 22.5x
P/S 7.3x 1.5x 6.7x
P/B 0.8x 6.0x 5.9x
P/Tangible book 0.8x 8.7x 8.2x
EV/EBITDA -0.3x 11.5x 20.3x
EV/EBIT -0.3x 14.8x 28.8x
EV/Revenue 1.0x 1.9x 7.3x
EV/FCF -0.4x 16.9x 52.0x
EV/Operating cash flow -0.5x 14.4x 24.7x
PEG (3Y EPS CAGR) 0.05 1.25 4.59

Growth

14 metrics
MetricASPIAVYLIN
Revenue growth (1Y) 573.4% 6.8% 8.2%
Revenue CAGR (3Y) 2,420% 4.2% 3.7%
Gross profit growth (1Y) 214.3% 7.8% 6.1%
Gross profit CAGR (3Y) – 7.4% 5.0%
Operating income growth (1Y) -200.2% 5.9% -0.2%
Operating income CAGR (3Y) -105.1% 10.1% 6.0%
Net income growth (1Y) -17.1% 1.8% -0.8%
Net income CAGR (3Y) -119.1% 13.6% 5.1%
EPS growth (1Y) 30.3% 4.6% 0.7%
EPS CAGR (3Y) -37.1% 16.1% 7.5%
Operating cash flow growth (1Y) -244.7% 42.6% 5.7%
Operating cash flow CAGR (3Y) -151.6% 12.4% 7.3%
Free cash flow growth (1Y) -182.5% 51.7% 0.1%
Free cash flow CAGR (3Y) -123.3% 20.6% -0.1%

Profitability

14 metrics
MetricASPIAVYLIN
Gross margin 18.3% 28.8% 47.9%
EBITDA margin -303.3% 16.4% 35.8%
Operating margin -321.1% 12.7% 25.3%
Pretax margin -443.4% 10.4% 25.2%
Net margin -380.3% 7.6% 19.3%
FCF margin -270.9% 11.1% 14.0%
Operating cash flow margin -219.8% 13.0% 29.6%
Return on equity -40.9% 30.1% 17.6%
Return on assets -20.2% 7.7% 8.1%
Return on invested capital -28.6% 14.4% 10.3%
Return on capital employed -19.4% 18.9% 12.6%
Asset turnover 0.1x 1.0x 0.4x
Cash conversion (OCF / net income) 0.6x 1.7x 1.5x
Stock comp / revenue 60.5% 0.3% 0.4%

Financial Health

11 metrics
MetricASPIAVYLIN
Debt / assets 10.4% 39.4% 30.3%
Debt / equity 0.2x 1.5x 0.7x
Net debt / EBITDA 2.1x 2.2x 1.8x
Debt / FCF -0.7x 3.5x 5.3x
Liabilities / assets 52.0% 73.9% 53.5%
Equity / assets 48.0% 26.1% 46.5%
Interest coverage -25.3x 8.2x 35.5x
Current ratio 3.9x 1.2x 0.9x
Quick ratio 3.7x 0.7x 0.6x
Cash ratio 3.6x 0.1x 0.3x
Altman Z-score -0.30 3.68 4.12

Shareholder Returns

7 metrics
MetricASPIAVYLIN
Dividend yield – 2.1% 1.2%
Net buyback yield -119.4% 2.6% 1.7%
Shareholder yield -119.4% 4.7% 2.9%
Payout ratio (earnings) – 41.8% 41.5%
Payout ratio (FCF) – 28.5% 57.3%
Dividend growth (1Y) – 3.5% 5.1%
Dividend CAGR (3Y) – 5.5% 5.9%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusASPIAVYLIN
Forward P/E – 17.7xFY2026 31.3xFY2026
EPS, next fiscal year $-0.45FY2026 $10.62FY2026 $16.79FY2026
EPS growth, next FY – +11.4%FY2026 +2.1%FY2026
EPS growth, the year after – +6.9% +13.6%
Revenue, next fiscal year $24.34MFY2026 $9.87BFY2026 $39.06BFY2026
Revenue growth, next FY +2.0%FY2026 +11.3%FY2026 +14.9%FY2026
Revenue growth, the year after +189.0% -0.3% -4.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersASPIAVYLIN
Held by institutions 50.3% 97.4% 85.2%
Institutions holding 189 784 2,326
Change in shares held, QoQ +3.3% +2.7% +4.2%
Institutions buying 114 383 1,215
Institutions selling 53 273 766
Buyers to sellers 2.15 1.40 1.59

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ASPIAVYLIN
ASPI 1.00 0.03 -0.05
AVY 0.03 1.00 0.42
LIN -0.05 0.42 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ASPI, AVY and LIN?

Linde (LIN) is the largest by market capitalisation: ASP Isotopes (ASPI) $195.12M, Avery Dennison (AVY) $14.32B, Linde (LIN) $243.32B.

Which stock is cheaper, ASPI, AVY and LIN?

Avery Dennison (AVY) trades on the lowest price-to-earnings ratio (ASP Isotopes (ASPI) -1.7x, Avery Dennison (AVY) 20.2x, Linde (LIN) 34.7x). On next year's consensus earnings, Avery Dennison (AVY) is cheapest (Avery Dennison (AVY) 17.7x, Linde (LIN) 31.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

ASP Isotopes (ASPI) grew revenue fastest over the trailing twelve months: ASP Isotopes (ASPI) +573.4%, Avery Dennison (AVY) +6.8%, Linde (LIN) +8.2%.

Which company is more profitable?

Linde (LIN) has the highest net margin (ASP Isotopes (ASPI) -380.3%, Avery Dennison (AVY) 7.6%, Linde (LIN) 19.3%). On return on invested capital, Avery Dennison (AVY) leads (ASP Isotopes (ASPI) -28.6%, Avery Dennison (AVY) 14.4%, Linde (LIN) 10.3%).

Which stock has performed better?

Over the past year Linde (LIN) returned the most: ASP Isotopes (ASPI) -78.3%, Avery Dennison (AVY) +6.6%, Linde (LIN) +22.7%. Over five years, Linde (LIN) compounded fastest (Avery Dennison (AVY) -3.5%/yr, Linde (LIN) +9.3%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Avery Dennison (AVY) has the highest dividend yield: ASP Isotopes (ASPI) 0.00%, Avery Dennison (AVY) 0.02%, Linde (LIN) 0.01%. ASP Isotopes (ASPI) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Linde (LIN) has been the steadiest (ASP Isotopes (ASPI) 99.0%, Avery Dennison (AVY) 24.0%, Linde (LIN) 19.1%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ASPI, AVY and LIN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Linde (LIN) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.